Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women

Acta Diabetologica

Volumn 49, Issue 1 SUPPL., 2012, Pages

  King, George A ^a   Deemer, Sarah E ^a   Thompson, Dixie L ^b  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Adiponectin; Hispanic; HOMA; Pre menopausal

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HISPANIC; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK ASSESSMENT; UNITED STATES; BLOOD; CARDIOVASCULAR DISEASE; ETHNOLOGY; MIDDLE AGED; RISK FACTOR;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 84875965068     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0192-6     Document Type: Article

References (35)

1. Oh DK, Ciaraldi T, Henry RK (2007) Adiponectin in health and disease. Diabetes Obes Metab 9:282-289
2. Havel PJ (2002) Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51-59
3. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
4. Wolf G (2003) Adiponectin: a regulator of energy homeostasis. Nutr Rev 61:290-292
5. Heidemann C, Sun Q, vanDam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB (2008) Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149:307-316
6. Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Luna MTT, Gomez-Perez FJ (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93:4075-4079
7. Kim J-Y, Wall Evd, Laplante M, Azzara A, Trujillo ME, Hofman SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE (2007) Obesity-associated improvements in metabolic profile though expansion of adipose tissue. J Clin Invest 117:2621-2637
8. Hadi HA, Suwaidi JA (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3:853-876
9. Triggle C (2008) The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes. Timely Top Med Cardiovasc Dis p E3
10. Giannessi D, Maltinti M, DelRy S (2007) Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res 56:459-467
11. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and the metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29-33
12. CDC (2007) National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. U.S. Department of Health and Human Services, Atlanta
13. American College of Sports Medicine (2006) Preparticipation health screening and risk stratification. In: Whaley MH, Brubaker BH, Otto RM (eds) ACSM's guidelines for exercise testing and prescription, 7th edn. Lippincott Williams & Wilkins, Baltimore, p 22
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment - insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia 28:412-419
15. Li S, Shin HJ, Ding EL, vanDam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179-188
16. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359
17. Ogden CL, Carroll MD, McDowell MA, Flegal KM (2007) Obesity among adults in the United States - no statistically significant change since 2003-2004. NCHS data brief no 1. National Center for Health Statistics, Hyattsville
18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponecinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
19. Hulver MH, Saleh O, MacDonald KG, Pories WJ, Barakat HA (2004) Ethnic differences in adiponectin levels. Metabolism 53:1-3
20. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R (2008) Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57:980-986
21. Hanley AJG, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfield C, Saad MF, Rotter JI, Guo X, Chen Y-DI, Bryer-Ash M, Norris JM, Haffner SM (2007) Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African Americans. J Clin Endocrinol Metab 92:2665-2671
22. Grundy SM (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595-2600
23. Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108:1546-1551
24. Despres JP (2001) Health consequences of visceral adiposity. Ann Med 33:534-541
25. Behre CJ (2007) Adiponectin, obesity, and athersclerosis. Scand J Clin Lab Invest 67:449-458
26. Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T (2006) Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 98:1603-1608
27. Laughlin GA, Barrett-Connor E, May S, Langenberg C (2007) Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo Study. Am J Epidemiol 165:164-174
28. Lu G, Chiem A, Anuurad E, Havel PJ, Pearson TA, Ormsby B, Berglund L (2007) Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. Trans Res 149:317-323
29. Rathmann W, Haastert B, Herder C, Hauner H, Koenig W, Meisinger C, Holle R, Giani G (2007) Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000. Int J Obes 31:770-776
30. Wildman RP, Mancuso P, Wang C, Kim M, Scherer PE, Sowers MR (2008) Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations. Int J Obes 32:740-748
31. Rothenbacher D, Brenner H, März W, Koenig W (2005) Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26:1640-1646
32. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y, Yeh J, Best LG (2005) Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 25:e15-e16
33. Lawlor DA, Smith GD, Ebrahim S, Thompson C, Sattar N (2005) Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 90:5677-5683
34. Toth PP (2004) High density lipoprotein and cardiovascular risk. Circulation 109:1809-1812
35. Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O'Brien SJ, Altshuler D, Daly MJ, Reich D (2004) Methods for high-density admixture mapping of disease genes. Am J Hum Genet 74:979-1000